In 2026, the URGO Group reached a major milestone in its development by exceeding €1 billion in turnover.
This turning point marks a new phase for our French company, which remains 100% family-owned and continues to grow by building on a solid industrial model, a strong capacity for innovation and a clear international ambition.
A historic milestone for a French family-run business
Reaching €1 billion in turnover marks a significant milestone in URGO’s history. Over the past 25 years, our Group has grown from €150 million to this landmark figure, reflecting a steady and controlled growth trajectory.
This progress is based on key strategic decisions:
- an ongoing commitment to innovation,
- a strong industrial presence in France,
- and dynamic international expansion.
Today, URGO employs 4,000 people across 20 countries and remains committed to a bold ambition: to improve patient care through ever more innovative solutions.
€150 million to prepare for the future
Beyond this symbolic milestone, URGO has confirmed its commitment to accelerating its growth with the announcement of an investment plan worth €150 million in France over the period 2026–2027.
This ambitious programme aims to:
- strengthen the Group’s industrial capabilities,
- step up research and development efforts,
- support innovation, particularly in groundbreaking projects such as artificial skin,
- modernise production sites and support the transformation of industrial equipment.
These investments form part of a long-term strategy that is consistent with the Group’s core values: manufacturing in France, maintaining control over its expertise, and ensuring the quality of its healthcare solutions.
A tangible impact on local areas and employment
This investment plan will also have a direct impact on the regions where the Group operates, with the creation of new jobs in the fields of research, engineering, production and logistics.
We are thus reaffirming our commitment to French industrial development and health sovereignty by keeping a significant proportion of our production within the country.
An unwavering ambition: to innovate for better care
For URGO, reaching the one-billion-euro mark is not an end in itself, but rather a starting point.
We are continuing to drive innovation in order to offer ever more effective and accessible solutions for the benefit of patients and healthcare professionals.
This journey is, above all, the result of a collective effort, driven by dedicated teams and a strong corporate culture that combines high standards, an entrepreneurial spirit and a family-oriented ethos.
In the press
Urgo annonce 150 millions d’euros d’investissement en 2026-2027
